Attached files
file | filename |
---|---|
EX-10 - ANALYTICA BIO-ENERGY CORP | news2020one.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant To Section 18 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 28, 2014
ANALYTICA BIO-ENERGY CORP.
(Exact name of small business issuer as specified in its charter)
Delaware 333-127170 98-0476582
(State or other Jurisdiction (Commission File Number) (IRS Employer Identification
of incorporation) Number)
1896 Stoneybrook Court
Mississauga, Ontario, CANADA L5L 3W2
(Address of principal executive offices, including zip code)
(905) 824-6200
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
The definitive agreement that came into effect on September 30, 2013 was completed on February 28, 2014 with the transfer of the 8,000,000 shares of restricted common shares to the Sellers
Item 9.01
Financial Statements and Exhibits
(d) Exhibits
Exhibit Description
Definitive Agreement
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: February 28, 2014 Analytica Bio - Energy Corp.
/S/
____________________
Luiz A. Brasil, CEO